Hebt u iets om te verkopen?

Race in a Bottle: The Story of BiDil and Racialized Medicine in a Post-Genomic

Objectstaat:
Goed
Prijs:
US $11,34
OngeveerEUR 10,62
Verzendkosten:
Gratis Standard Shipping. Details bekijkenvoor verzending
Bevindt zich in: Sparks, Nevada, Verenigde Staten
Levering:
Geschatte levering tussen do, 27 jun en di, 2 jul tot 43230
De levertijd wordt geschat met onze eigen methode op basis van onder meer de nabijheid van de koper ten opzichte van de objectlocatie, de geselecteerde verzendservice, en de verzendgeschiedenis van de verkoper. De leveringstermijnen kunnen variëren, vooral gedurende piekperiodes.
Retourbeleid:
30 dagen om te retourneren. Koper betaalt voor retourzending. Details bekijken- voor meer informatie over retourzendingen
Betalingen:
     

Winkel met vertrouwen

eBay-topverkoper
Betrouwbare verkoper, snelle verzending en eenvoudige retourzending. 
Geld-terug-garantie van eBay
Ontvang het object dat u hebt besteld of krijg uw geld terug. 

Verkopergegevens

Ingeschreven als zakelijke verkoper
De verkoper neemt de volledige verantwoordelijkheid voor deze aanbieding.
eBay-objectnummer:364271422385
Laatst bijgewerkt op 26 mrt 2024 22:15:19 CETAlle herzieningen bekijkenAlle herzieningen bekijken

Specificaties

Objectstaat
Goed: Een boek dat is gelezen, maar zich in goede staat bevindt. De kaft is zeer minimaal beschadigd ...
Book Title
Race in a Bottle: The Story of BiDil and Racialized Medicine in a
Publication Date
2012-12-11
Pages
328
ISBN
9780231162982
Subject Area
Medical, Social Science, Political Science
Publication Name
Race in a Bottle : the Story of Bidil and Racialized Medicine in a Post-Genomic Age
Publisher
Columbia University Press
Item Length
0.9 in
Subject
Ethics, Public Health, Chemotherapy, Public Policy / General, Ethnic Studies / African American Studies
Publication Year
2012
Type
Textbook
Format
Hardcover
Language
English
Item Height
0.1 in
Author
Jonathan Kahn
Item Weight
20.2 Oz
Item Width
0.6 in
Number of Pages
328 Pages

Over dit product

Product Information

Approved by the FDA in 2005, BiDil was originally touted as a pathbreaking therapy to treat heart failure in black patients and help underserved populations. Upon closer examination, Jonathan Kahn reveals BiDil became racial through legal maneuvering and commercial pressure as much as through medical understandings of how the drug worked. Using BiDil as a case study, Kahn broadly examines the distinct politics informing the use of race in medicine and the very real health disparities caused by racism and social injustice that are being cast as a function of genetic difference. Kahn shows that, just as genetics is a complex field requiring sensitivity and expertise, so too is race, particularly in the field of biomedicine.

Product Identifiers

Publisher
Columbia University Press
ISBN-10
0231162987
ISBN-13
9780231162982
eBay Product ID (ePID)
117142722

Product Key Features

Number of Pages
328 Pages
Language
English
Publication Name
Race in a Bottle : the Story of Bidil and Racialized Medicine in a Post-Genomic Age
Publication Year
2012
Subject
Ethics, Public Health, Chemotherapy, Public Policy / General, Ethnic Studies / African American Studies
Type
Textbook
Subject Area
Medical, Social Science, Political Science
Author
Jonathan Kahn
Format
Hardcover

Dimensions

Item Height
0.1 in
Item Weight
20.2 Oz
Item Length
0.9 in
Item Width
0.6 in

Additional Product Features

Intended Audience
Scholarly & Professional
LCCN
2012-023167
Dewey Edition
23
Reviews
Kahn's book should be required reading. At a time when the ties between scientific researchers and the pharmaceutical industry are becoming ever more entangled, Race in a Bottle provides valuable insights into the consequences of these connections for health and health care - and, importantly, for what passes as knowledge., [Jonathan Kahn's] rich portrayal of the changing meaning and uses of race in the wake of genomics makes this book a 'must read' and 'must assign' for all sociologists of race and ethnicity., [Jonathan Kahn's] rich portrayal of the changing meaning and uses of race in the wake of genomics makes this book a "must read" and "must assign" for all sociologists of race and ethnicity., Jonathan Kahn's approach offers an airtight analysis of the commoditization of race in pharmaceutical development, and Race in a Bottle should be of interest and deep concern to numerous audiences., Jonathan Kahn is the undisputed Hercules Poirot of biomedicine. His unraveling of the nonsense, non-science, and complicated illogic that allowed the vasodilator BiDil to be approved by the FDA exclusively for 'black' patients is as compelling a read as any good mystery. This riveting book details what happens to scientific method when profit motive drives the marketing of a drug to the extent that its curative properties are touted as race-specific -- even when they're not. Genetic variation in humans has no correlation to the shifting historical meanings of race, yet pharmaceutical companies continue to force the square peg of social category into the round hole of scientific fact. Race in a Bottle is a brilliant deconstruction of the kinds of thought processes that make for bad policy, bad medicine, and ultimately endanger our health as a species., Kahn's approach offers an airtight analysis of the commoditization of race in pharmaceutical development, and Race in a Bottle should be of interest and deep concern to numerous audiences., Race in a Bottle is lucid and energetic, with fascinating and little-known evidence about clinical trials, the federal regulatory and patent systems, and the history of racial classification.... Kahn offers a heartfelt and persuasive case against allowing race to be reduced to biology., Jonathan Kahn has produced a major and unique contribution, giving readers a 'big picture' understanding of this vital issue by integrating empirically grounded analysis of real controversies into a detailed conceptual roadmap. This is a substantial piece of scholarship and will be of interest to anyone concerned with the escalating, even geometrically expanding use of the concept of race in science and medicine., Kahn expertly weaves together the legal and ethical ramifications of continuing to pursue racialized drugs.... No background in health sciences or genetics is necessary to understand this work., [Kahn] skillfully uses the story of the drug BiDil... as the backdrop for examining the expanding role of race in medical genomics, even when the same science has called the existence of race into serious doubt., Jonathan Kahn brilliantly exposes the stunning truth behind new race-based medicines: they are driven by market incentives, not scientific evidence. Based on meticulous research and astute analysis, Kahn constructs a gripping, devastating portrait of profit motivating the use of race in genetic research and pharmaceuticals. Race in a Bottle is absolutely essential for understanding why the myth of biological race has reemerged in genomic science and biotechnology and how it is distorting research, damaging pubic health, and undermining justice in our supposedly post-racial society., [ Race in a Bottle ] tackle[s] one of the most important concerns pertaining to race facing our society today.... Must-read material.New Scientist, [ Race in a Bottle ] tackle[s] one of the most important concerns pertaining to race facing our society today.... Must-read material., Jonathan Kahn is the undisputed Hercules Poirot of biomedicine. His unraveling of the nonsense, non-science, and complicated illogic that allowed the vasodilator BiDil to be approved by the FDA exclusively for 'black' patients is as compelling a read as any good mystery. This riveting book details what happens to scientific method when profit motive drives the marketing of a drug to the extent that its curative properties are touted as race-specific-even when they're not. Genetic variation in humans has no correlation to the shifting historical meanings of race, yet pharmaceutical companies continue to force the square peg of social category into the round hole of scientific fact. Race in a Bottle is a brilliant deconstruction of the kinds of thought processes that make for bad policy, bad medicine, and ultimately endanger our health as a species., Jonathan Kahn is the undisputed Hercules Poirot of biomedicine. His unraveling of the nonsense, non-science, and complicated illogic that allowed the vasodilator BiDil to be approved by the FDA exclusively for 'black' patients is as compelling a read as any good mystery. This riveting book details what happens to scientific method when profit motive drives the marketing of a drug to the extent that its curative properties are touted as race-specific--even when they're not. Genetic variation in humans has no correlation to the shifting historical meanings of race, yet pharmaceutical companies continue to force the square peg of social category into the round hole of scientific fact. Race in a Bottle is a brilliant deconstruction of the kinds of thought processes that make for bad policy, bad medicine, and ultimately endanger our health as a species., A powerful saga packed with engrossing twists and turns of plot and filled with food for thought and debate on the politics and health implications of racial perception., Mr. Kahn deserves credit for teasing out all the daunting complexities behind these events, including the details of genetic analysis, the perils of racial determinations, and the minutiae of patent law., Mr. Kahn deserves credit for teasing out all the daunting complexities behind these events, including the details of genetic analysis, the perils of racial determinations, and the minutiae of patent law.New York Times, Kahn expertly weaves together the legal and ethical ramifications of continuing to pursue racialized drugs...no background in health sciences or genetics is necessary to understand this work., [Kahn] seems as much at home discussing epidemiology and drug marketing as he does the history of US race relations and the intricacies of patenting.... Magnificent., Jonathan Kahn is the undisputed Hercules Poirot of biomedicine. His unraveling of the nonsense, non-science and complicated illogic that allowed the vasodilator Bidil to be approved by the FDA exclusively for "black" patients is as compelling a read as any good mystery. This riveting book details what happens to scientific method when profit motive drives the marketing of a drug to the extent that its curative properties are touted as race-specific -- even when they're not. Genetic variation in humans has no correlation to the shifting historical meanings of race, yet pharmaceutical companies continue to force the square peg of social category into the round hole of scientific fact. Race in a Bottle is a brilliant deconstruction of the kinds of thought processes that make for bad policy, bad medicine and ultimately endanger our health as a species.
Grade from
College Graduate Student
Illustrated
Yes
Dewey Decimal
616.12906108996073
Lc Classification Number
Rm666.H7k34 2012
Table of Content
Acknowledgments INTRODUCTION: Race and Medicine: Framing [Is] the Problem 1. ORGANIZING RACE: Paths Toward the Re-Biologization of Race in Modern Biomedical Research, Practice, and Product Development 2. THE BIRTH OF BIDIL: How a Drug Becomes "Ethnic" 3. STATISTICAL MISCHIEF AND RACIAL FRAMES FOR DRUG DEVELOPMENT AND MARKETING 4. CAPITALIZING [ON] RACE IN DRUG DEVELOPMENT 5. RACE-ING PATENTS/PATENTING RACE: An Emerging Political Geography of Intellectual Property in Biotechnology 6. NOT FADE AWAY: The Persistence of Race and the Politics of the "Meantime" in Pharmacogenomics 7. FROM DISPARITY TO DIFFERENCE: The Politics of Racial Medicine CONCLUSIONS AND RECOMMENDATIONS Notes Index
Copyright Date
2012

Objectbeschrijving van de verkoper

Informatie van zakelijke verkoper

Alibris, Inc.
Rob Lambert
2560 9th St
Ste 215
94710-2565 Berkeley, CA
United States
Contactgegevens weergeven
:liam-Emoc.sirbila@90_skoob_flah
Ik verklaar dat al mijn verkoopactiviteiten zullen voldoen aan alle wet- en regelgeving van de EU.
AlibrisBooks

AlibrisBooks

98,5% positieve feedback
1,8M objecten verkocht

Gedetailleerde verkopersbeoordelingen

Gemiddelde van de afgelopen 12 maanden

Nauwkeurige beschrijving
4.9
Redelijke verzendkosten
4.9
Verzendtijd
4.9
Communicatie
4.9
Ingeschreven als zakelijke verkoper

Feedback verkoper (463.476)

d***d (332)- Feedback gegeven door koper.
Afgelopen maand
Geverifieerde aankoop
Great transaction!
7***7 (1532)- Feedback gegeven door koper.
Afgelopen maand
Geverifieerde aankoop
wonderful condition!!!
8***d (17)- Feedback gegeven door koper.
Afgelopen maand
Geverifieerde aankoop
Book in very good shape, speedy delivery.